Bio-Techne Enhances Spatial Biology Revolutionizing Diagnostics
Bio-Techne Unveils Innovative Solutions in Spatial Biology
Bio-Techne Corporation (NASDAQ: TECH), a reputable name in life science tools and diagnostic products, has recently made significant strides within its spatial biology portfolio. These innovations combine the power of RNAscope™ ISH technology with the advanced Lunaphore COMET™ platform, allowing researchers and pathologists to uncover simultaneous RNA and protein markers from the same tissue section.
The Role of RNAscope™ Technology
The RNAscope™ technology stands at the forefront of enabling pathologists and histologists to identify clinically relevant biomarkers directly within anatomic pathology workflows. This innovative approach allows detection of critical elements such as viral markers, secreted proteins, point mutations, and chromosomal translocations, thereby enhancing the overall capability in various biological analyses.
Comprehensive Multiomic Analysis with COMET™
The Lunaphore COMET™ technology complements RNAscope™ by offering fully automated high-throughput hyperplex analysis. This synergy significantly accelerates the spatial multiomic workflows and unveils deeper biological insights essential for effective diagnostics.
Facilitating Diagnostic Applications in Clinical Settings
Recent scientific discussions have highlighted the diagnostic potential of these technologies, particularly in lymphoid malignancies. For instance, studies have demonstrated how RNAscope™ can be utilized for B-cell clonality assessment by detecting IGLL5, showcasing its dedication to enhancing clinical utility.
Advances in Diagnostic Workflows
The COMET™ platform has also been pivotal in spatial profiling of lymphoid malignancies using advanced 21-plex seqIF™ panels. Such findings underscore how spatial biology tools can seamlessly integrate into diagnostic workflows, especially where there is limited tissue for analysis.
Showcasing Innovations at the NSH Convention
Bio-Techne is set to showcase its groundbreaking innovations at the National Society of Histotechnology (NSH) Convention. This event serves as an important meeting point for experts in the field, taking place from September 26 to 30 in a waterfront venue conducive for networking and discussions.
Presentations to Watch
Notable presentations at the convention include:
- RNAscope™ for Routine Anatomic Pathology: Dr. Ryan Bremer will present the advancements of RNAscope™ and its benefits over traditional methods, emphasizing the ease of incorporating RNAscope into existing workflows.
- New Insights in B-cell Clonality: Dr. Ishani Das has researched the comparative performance of RNAscope™ for assessing B-cell clonality and will present her findings, which highlight the concurrent detection of IGLL5.
- seqIF™ Panel for Lymphoid Malignancies: Dr. Antonio Sorrentino's poster will illustrate how the COMET technology can improve the diagnosis of lymphoid malignancies using clinically validated antibodies with the seqIF™ panel.
Partnerships and Strategic Collaborations
The partnership between Bio-Techne and Leica Biosystems continues to flourish, with a waterfront reception set at Parker's Lighthouse aimed at bringing industry professionals together. This collaboration underscores the shared vision of advancing spatial biology and diagnostic capabilities.
Dr. Matt McManus, the President of the Diagnostics and Spatial Biology Segment, expressed excitement about these developments. He noted, "The progress we have made in advancing traditional in situ hybridization is thrilling. We are focused on creating innovative tools that play a role in unlocking the molecular drivers of disease, ultimately transforming patient care."
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is dedicated to providing industry-leading tools and bioactive reagents that serve both research and clinical diagnostics communities. The company emphasizes the need for accurate testing and diagnosis in various diseases, with a mission aligned towards aiding drug discovery and advancing clinical testing capabilities. With a robust portfolio generating significant annual sales and a dedicated workforce, Bio-Techne is positioned as a leader in life sciences.
Frequently Asked Questions
What advancements has Bio-Techne made in spatial biology?
Bio-Techne has enhanced its spatial biology portfolio by integrating RNAscope™ technology with the Lunaphore COMET™ platform, enabling simultaneous detection of RNA and proteins.
How does RNAscope™ improve diagnostic workflows?
RNAscope™ allows for the detection of crucial biomarkers, such as viral markers and point mutations, directly within routine pathology workflows, leading to more effective diagnostics.
What is the significance of the NSH Convention?
The NSH Convention provides a platform for experts to showcase innovations and discuss advancements in histotechnology, including presentations by Bio-Techne.
Who are the speakers at the NSH Convention related to Bio-Techne?
Dr. Ryan Bremer, Dr. Ishani Das, and Dr. Antonio Sorrentino are set to present their research and findings relevant to spatial biology tools at the convention.
What is the mission of Bio-Techne Corporation?
Bio-Techne aims to provide innovative tools and reagents that support research and clinical diagnostics, ultimately assisting in understanding biological processes and enhancing patient care.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
